Nothing Special   »   [go: up one dir, main page]

ATE81135T1 - Aktive thymopentin-analoga. - Google Patents

Aktive thymopentin-analoga.

Info

Publication number
ATE81135T1
ATE81135T1 AT85304559T AT85304559T ATE81135T1 AT E81135 T1 ATE81135 T1 AT E81135T1 AT 85304559 T AT85304559 T AT 85304559T AT 85304559 T AT85304559 T AT 85304559T AT E81135 T1 ATE81135 T1 AT E81135T1
Authority
AT
Austria
Prior art keywords
active
thymopentin
analogues
thymopentin analogues
splenin
Prior art date
Application number
AT85304559T
Other languages
English (en)
Inventor
Gideon Goldstein
George Heavner
Daniel Kroon
Tapan Audhya
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of ATE81135T1 publication Critical patent/ATE81135T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C07K14/662—Thymopoietins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Control Of Eletrric Generators (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Control Of Charge By Means Of Generators (AREA)
  • Control Of Combustion (AREA)
AT85304559T 1984-06-27 1985-06-26 Aktive thymopentin-analoga. ATE81135T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/625,344 US4629723A (en) 1984-06-27 1984-06-27 Potent thymopentin analogs
EP85304559A EP0166612B1 (de) 1984-06-27 1985-06-26 Aktive Thymopentin-Analoga

Publications (1)

Publication Number Publication Date
ATE81135T1 true ATE81135T1 (de) 1992-10-15

Family

ID=24505633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85304559T ATE81135T1 (de) 1984-06-27 1985-06-26 Aktive thymopentin-analoga.

Country Status (14)

Country Link
US (2) US4629723A (de)
EP (1) EP0166612B1 (de)
JP (1) JPH0689029B2 (de)
KR (1) KR920006563B1 (de)
AT (1) ATE81135T1 (de)
AU (1) AU592309B2 (de)
CA (1) CA1269499A (de)
DE (1) DE3586697T2 (de)
DK (1) DK171238B1 (de)
FI (1) FI92325C (de)
IL (1) IL75637A (de)
NO (1) NO167924C (de)
NZ (1) NZ212461A (de)
ZA (1) ZA854832B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602483B2 (en) * 1985-01-18 1990-10-18 Immunetech Pharmaceuticals Immunoregulatory peptides
DE3619633A1 (de) * 1986-06-11 1987-12-17 Hoechst Ag Peptide mit einfluss auf die diurese und natriurese, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
HUT46044A (en) * 1986-11-21 1988-09-28 Richter Gedeon Vegyeszet Process for producing immunstimulant peptides inhibiting multiplication of leukaemic cells and pharmaceutics comprising same
IT1216908B (it) * 1987-03-19 1990-03-14 Eniricerche Spa Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
HU199878B (en) * 1987-06-19 1990-03-28 Berlin Chemie Veb Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
US5656601A (en) * 1987-06-19 1997-08-12 Berlin-Chemie Ag Acylated splenopentins, methods for their synthesis and their use
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
WO1989009229A1 (en) * 1988-03-31 1989-10-05 Immunobiology Research Institute, Inc. Treatment of hiv viremic patients with thymopentin
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
US4943477A (en) * 1988-09-27 1990-07-24 Mitsubishi Rayon Co., Ltd. Conductive sheet having electromagnetic interference shielding function
HU205143B (en) * 1988-09-30 1992-03-30 Immunobiology Res Inst Inc Process for producing peptides having t cell suppressor activity and pharmaceutical compositions comprising same
US5218089A (en) * 1988-12-23 1993-06-08 Sclavo S.P.A. Retro-inverso analogues of thymopentin and the method for their synthesis
IT1227908B (it) * 1988-12-23 1991-05-14 Eniricerche S P A Milano Sclav Nuovi analoghi retro-inversi della timopentina, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
EP0570478A4 (en) * 1991-02-04 1994-08-17 Univ George Washington Mb-40 peptide that enhances the production of interleukin-1 and modulates age-associated immune response
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
US5215964A (en) * 1991-06-03 1993-06-01 Immunobiology Research Institute, Inc. Peptides useful in regulating the immune and nervous systems
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
WO1994025482A1 (en) * 1993-04-23 1994-11-10 Evans Herbert J Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
CN101168560B (zh) * 2006-10-23 2012-09-05 江苏正大天晴药业股份有限公司 N-取代肽酰胺，其药物组合物与用途
CN117860921A (zh) * 2021-12-16 2024-04-12 江西中医药大学 一种胸腺五肽衍生物tp-7在制备肿瘤诊断和/或治疗试剂中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077949A (en) * 1973-12-28 1978-03-07 Sloan-Kettering Institute For Cancer Research Polypeptide hormones of the thymus
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods
US4190646A (en) * 1975-11-11 1980-02-26 Sloan-Kettering Institute For Cancer Research Polypeptide compositions and methods
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
CA1157466A (en) * 1979-04-12 1983-11-22 Gideon Goldstein Peptides having thymopoietin-like activity
JPS55149237A (en) * 1979-04-12 1980-11-20 Ortho Pharma Corp Thymopoietin active peptide
US4261886A (en) * 1980-03-13 1981-04-14 Ortho Pharmaceutical Corporation Peptides having thymopoietin-like activity
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung
US4309340A (en) * 1980-03-31 1982-01-05 American Home Products Corporation Polypeptide compositions
US4361673A (en) * 1980-09-19 1982-11-30 American Home Products Corporation Polypeptide compositions
US4305852A (en) * 1980-10-20 1981-12-15 American Home Products Corporation Polypeptide compositions
US4505853A (en) * 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
DE3421614A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von pentapeptiden mit wirkung auf das immunsystem und zwischenprodukte dieses verfahrens

Also Published As

Publication number Publication date
FI92325B (fi) 1994-07-15
DE3586697T2 (de) 1993-02-11
JPS6118799A (ja) 1986-01-27
DE3586697D1 (en) 1992-11-05
NZ212461A (en) 1988-10-28
FI92325C (fi) 1994-10-25
NO167924C (no) 1991-12-27
US4629723A (en) 1986-12-16
AU592309B2 (en) 1990-01-11
DK289285A (da) 1985-12-28
USRE34165E (en) 1993-01-19
IL75637A (en) 1990-02-09
DK171238B1 (da) 1996-08-05
CA1269499A (en) 1990-05-22
ZA854832B (en) 1987-02-25
EP0166612B1 (de) 1992-09-30
EP0166612A3 (en) 1987-08-05
NO167924B (no) 1991-09-16
IL75637A0 (en) 1985-10-31
JPH0689029B2 (ja) 1994-11-09
EP0166612A2 (de) 1986-01-02
KR920006563B1 (ko) 1992-08-08
NO852567L (no) 1985-12-30
FI852522L (fi) 1985-12-28
DK289285D0 (da) 1985-06-26
KR860000314A (ko) 1986-01-28
AU4421585A (en) 1986-01-02
FI852522A0 (fi) 1985-06-26

Similar Documents

Publication Publication Date Title
ATE81135T1 (de) Aktive thymopentin-analoga.
EP0165033A3 (de) Verbindungen von Thymopentin-Type mit konformationäler Beschränkung
IT8321083A0 (it) Analoghi retro-invertiti del pentapeptide potenziante la bradichinina bpp5a e metodi per laloro preparazione.
BG46598A3 (en) Method for preparation of alpha- heterocyclic substituted tolunitriles
NO870240D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
NO872712L (no) FremgangsmŸte for fremstilling av kalsiumholdige preparater.
NO163619C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro- 2-heterocykloalkylpyrido(4,3)indoler.
IT8421622A0 (it) Procedimento per la preparazione di peptidi.
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
AU566133B2 (en) New polypeptide from thymus glands
IT8419142A0 (it) Analoghi retro-invertiti esapeptidici c-terminali della sostanza p.
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
IT8567535A1 (it) Procedimento per la preparazione di amminoidrossicefamcarbossilati.
IT1230068B (it) Procedimento per la preparazione di n sulfoniluree.
NO870435D0 (no) Tetningssystem.
IT8321507A0 (it) Procedimento di preparazione fermentativa di l-leucina.
DE3782199D1 (de) Biologisch aktive peptide tan-866.
ES8401320A1 (es) "un procedimiento para preparar composiciones farmaceuticas a base de sales de teofilina y aminoacidos basicos".
IT1228559B (it) Procedimento per la preparazione di enzima mieloperossidasi.
ATE69240T1 (de) Mitogene peptide.
DE3768106D1 (de) Kompressorsystem.
NO883008D0 (no) Peptidforbindelser.
IT8621699A0 (it) Procedimento per la realizzazione di calzature e calzature ottenute tramite tale procedimento.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time